These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 10861451)

  • 21. nm23 expression in tissue sections and tumor effusion cells of ovarian neoplasms.
    Harłozińska A; Bar JK; Gerber J
    Int J Cancer; 1996 Oct; 69(5):415-9. PubMed ID: 8900377
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression of TGFß1 and its receptors is associated with biological features of ovarian cancer and sensitivity to paclitaxel/carboplatin.
    Komiyama S; Kurahashi T; Ishikawa M; Tanaka K; Komiyama M; Mikami M; Udagawa Y
    Oncol Rep; 2011 Apr; 25(4):1131-8. PubMed ID: 21249319
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Study of T lymphocytes infiltrating peritoneal metastases in advanced ovarian cancer: associations with vascular endothelial growth factor levels and prognosis in patients receiving platinum-based chemotherapy.
    Tsiatas ML; Gyftaki R; Liacos C; Politi E; Rodolakis A; Dimopoulos MA; Bamias A
    Int J Gynecol Cancer; 2009 Nov; 19(8):1329-34. PubMed ID: 20009885
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reduced growth, increased vascular area, and reduced response to cisplatin in CD13-overexpressing human ovarian cancer xenografts.
    van Hensbergen Y; Broxterman HJ; Rana S; van Diest PJ; Duyndam MC; Hoekman K; Pinedo HM; Boven E
    Clin Cancer Res; 2004 Feb; 10(3):1180-91. PubMed ID: 14871998
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Overexpression of epithelial cell adhesion molecule in primary, metastatic, and recurrent/chemotherapy-resistant epithelial ovarian cancer: implications for epithelial cell adhesion molecule-specific immunotherapy.
    Bellone S; Siegel ER; Cocco E; Cargnelutti M; Silasi DA; Azodi M; Schwartz PE; Rutherford TJ; Pecorelli S; Santin AD
    Int J Gynecol Cancer; 2009 Jul; 19(5):860-6. PubMed ID: 19574774
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Over-expression of hypoxia-inducible factor 1 alpha in ovarian clear cell carcinoma.
    Lee S; Garner EI; Welch WR; Berkowitz RS; Mok SC
    Gynecol Oncol; 2007 Aug; 106(2):311-7. PubMed ID: 17532031
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Significant expression of vascular endothelial growth factor/vascular permeability factor in mouse ascites tumors.
    Luo JC; Yamaguchi S; Shinkai A; Shitara K; Shibuya M
    Cancer Res; 1998 Jun; 58(12):2652-60. PubMed ID: 9635593
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increased levels of laminin in ascitic fluid of patients with ovarian cancer.
    Byers LJ; Osborne JL; Carson LF; Carter JR; Haney AF; Weinberg JB; Ramakrishnan S
    Cancer Lett; 1995 Jan; 88(1):67-72. PubMed ID: 7850775
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Application Value of HNF-1β Transcription Factor in the Diagnosis of Ovarian Clear Cell Carcinoma.
    Huang W; Cheng X; Ji J; Zhang J; Li Q
    Int J Gynecol Pathol; 2016 Jan; 35(1):66-71. PubMed ID: 26166716
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Recent advances on ovarian epithelial cancer: definition, subtypes and pathologic features].
    Guo DH; Zheng WX
    Zhonghua Bing Li Xue Za Zhi; 2013 Sep; 42(9):624-8. PubMed ID: 24314254
    [No Abstract]   [Full Text] [Related]  

  • 31. High-affinity folate receptor in human ovary, serous ovarian adenocarcinoma, and ascites: radioligand binding mechanism, molecular size, ionic properties, hydrophobic domain, and immunoreactivity.
    Holm J; Hansen SI; Høier-Madsen M; Birn H; Helkjaer PE
    Arch Biochem Biophys; 1999 Jun; 366(2):183-91. PubMed ID: 10356282
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Urinary trypsin inhibitor, a Kunitz-type protease inhibitor, modulates tumor necrosis factor-stimulated activation and translocation of protein kinase C in U937 cells.
    Kobayashi H; Sugino D; Terao T
    Int J Oncol; 1998 Jan; 12(1):95-105. PubMed ID: 9454892
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Integrin-linked kinase expression increases with ovarian tumour grade and is sustained by peritoneal tumour fluid.
    Ahmed N; Riley C; Oliva K; Stutt E; Rice GE; Quinn MA
    J Pathol; 2003 Oct; 201(2):229-37. PubMed ID: 14517840
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Expression of folate receptor alpha in ovarian epithelial tumors].
    Shen DH; Xie JL; Zhang YL; Wang Y
    Zhonghua Bing Li Xue Za Zhi; 2010 Nov; 39(11):747-51. PubMed ID: 21215165
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vascular endothelial growth factor in ovarian cyst fluid.
    Boss EA; Massuger LF; Thomas CM; Geurts-Moespot A; Boonstra H; Sweep CG
    Cancer; 2001 Jan; 91(2):371-7. PubMed ID: 11180084
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Matrix metalloproteinases (MMP9 and MMP2) induce the release of vascular endothelial growth factor (VEGF) by ovarian carcinoma cells: implications for ascites formation.
    Belotti D; Paganoni P; Manenti L; Garofalo A; Marchini S; Taraboletti G; Giavazzi R
    Cancer Res; 2003 Sep; 63(17):5224-9. PubMed ID: 14500349
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression and mutation of p53 in tumor effusion cells of patients with ovarian carcinoma: response to cisplatin-based chemotherapy.
    Bar JK; Harłozińska A; Popiela A; Noga L
    Tumour Biol; 2001; 22(2):83-91. PubMed ID: 11125280
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Mechanism of tumor cell-induced extracellular matrix degradation--inhibition of cell-surface proteolytic activity might have a therapeutic effect on tumor cell invasion and metastasis].
    Kobayashi H
    Nihon Sanka Fujinka Gakkai Zasshi; 1996 Aug; 48(8):623-32. PubMed ID: 8808830
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clear cell carcinoma has an expression pattern of cell cycle regulatory molecules that is unique among ovarian adenocarcinomas.
    Shimizu M; Nikaido T; Toki T; Shiozawa T; Fujii S
    Cancer; 1999 Feb; 85(3):669-77. PubMed ID: 10091740
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression of interleukin-18 in human ovarian carcinoma and normal ovarian epithelium: evidence for defective processing in tumor cells.
    Wang ZY; Gaggero A; Rubartelli A; Rosso O; Miotti S; Mezzanzanica D; Canevari S; Ferrini S
    Int J Cancer; 2002 Apr; 98(6):873-8. PubMed ID: 11948465
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.